BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36973536)

  • 21. Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival.
    Ebner F; Wöckel A; Janni W; Kreienberg R; Schwentner L; Wischnewsky M
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1823-1831. PubMed ID: 28439713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
    Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
    World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
    Giuliano AE; Hunt KK; Ballman KV; Beitsch PD; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; McCall LM; Morrow M
    JAMA; 2011 Feb; 305(6):569-75. PubMed ID: 21304082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
    Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
    JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
    Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
    Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy.
    Lim SZ; Kusumawidjaja G; Mohd Ishak HM; Tan BKT; Tan SY; Hamzah JL; Madhukumar P; Yong WS; Wong CY; Sim Y; Lim GH; Lim SH; Tan SM; Wong FY; Tan VKM
    Breast Cancer Res Treat; 2021 Oct; 189(3):837-843. PubMed ID: 34342766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the Success Rate of Repeat Sentinel Node Biopsy in Recurrent Breast Cancer.
    Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Roumen RM; Luiten EJ; Rutgers EJ; Wyndaele D; Rutten HJ; Nieuwenhuijzen GA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S529-35. PubMed ID: 26259754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy.
    Murphy BM; Hoskin TL; Degnim AC; Boughey JC; Hieken TJ
    Ann Surg Oncol; 2021 Dec; 28(13):8729-8739. PubMed ID: 34275042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
    Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
    Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes.
    Joo JH; Kim SS; Son BH; Ahn SD; Jung JH; Choi EK; Ahn SH; Lee JW; Kim HJ; Ko BS
    Cancer Res Treat; 2019 Jul; 51(3):1011-1021. PubMed ID: 30322228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
    de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
    Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Liberis A; Vavoulidis E; Margioula-Siarkou G; Vatopoulou A; Papanikolaou A; Mavromatidis G; Dinas K
    Arch Gynecol Obstet; 2022 Oct; 306(4):1221-1234. PubMed ID: 35249123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection.
    Nayyar A; Strassle PD; Shen MR; Black JA; Gallagher KK; McGuire KP
    Am J Surg; 2018 Oct; 216(4):706-712. PubMed ID: 30060915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy.
    Picado O; Khazeni K; Allen C; Yakoub D; Avisar E; Kesmodel SB
    Breast Cancer Res Treat; 2018 Sep; 171(2):461-469. PubMed ID: 29869773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat surgery following breast conservation and intra-operative sentinel lymph node analysis for breast cancer.
    Dabbas N; Cutress RI; Wise M; Yiangou C; Agrawal A
    Surgeon; 2013 Oct; 11(5):235-40. PubMed ID: 23453370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer.
    Aubry S; Strassle PD; Maduekwe U; Downs-Canner S
    J Surg Res; 2020 Dec; 256():13-22. PubMed ID: 32679224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
    Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
    Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.